Cansino Biologics' Senior Management to Boost Stakeholding

MT Newswires Live06-24

Certain members of the higher management of Cansino Biologics (HKG:6185) are planning to buy H shares of the company in the open market within the next six months, a June 21 bourse disclosure said.

Chairman, CEO, and GM Xuefeng Yu; COO and deputy GM Shou Bai Chao; chief scientific officer and deputy GM Tao Zhu; and chief commercial officer and deputy GM Jing Wang will be purchasing additional shares.

Yu and Zhu are also controlling shareholders of the Chinese biotechnology company while Chao and Wang are executive directors.

The total value of the shares purchased by the interest parties is expected to be confined to HK$10 million.

Price (HKD): $20.10, Change: $+0.05, Percent Change: +0.25%

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2445073141?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-06-24 20:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2445073141","market":"nz","top_or_hot":-1,"title":"Cansino Biologics' Senior Management to Boost Stakeholding","media":"MT Newswires Live","content":"<html><body><p> Certain members of the higher management of Cansino Biologics (HKG:6185) are planning to buy H shares of the company in the open market within the next six months, a June 21 bourse disclosure said.</p><p>Chairman, CEO, and GM Xuefeng Yu; COO and deputy GM Shou Bai Chao; chief scientific officer and deputy GM Tao Zhu; and chief commercial officer and deputy GM Jing Wang will be purchasing additional shares.</p><p>Yu and Zhu are also controlling shareholders of the Chinese biotechnology company while Chao and Wang are executive directors.</p><p>The total value of the shares purchased by the interest parties is expected to be confined to HK$10 million.</p><p>Price (HKD): $20.10, Change: $+0.05, Percent Change: +0.25%</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cansino Biologics' Senior Management to Boost Stakeholding</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCansino Biologics' Senior Management to Boost Stakeholding\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-06-24 20:05 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Certain members of the higher management of Cansino Biologics (HKG:6185) are planning to buy H shares of the company in the open market within the next six months, a June 21 bourse disclosure said....</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0320765489.SGD","symbol_name":"FTIF - Franklin Mutual US Value A Acc SGD","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2445073141","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2445073141","pubTimestamp":1719230722,"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Certain members of the higher management of Cansino Biologics  are planning to buy H shares of the company in the open market within the next six months, a June 21 bourse disclosure said.Chairman, CEO, and GM Xuefeng Yu; COO and deputy GM Shou Bai Chao; chief scientific officer and deputy GM Tao Zhu; and chief commercial officer and deputy GM Jing Wang will be purchasing additional shares.Yu and Zhu are also controlling shareholders of the Chinese biotechnology company while Chao and Wang are executive directors.The total value of the shares purchased by the interest parties is expected to be confined to HK$10 million.Price : $20.10, Change: $+0.05, Percent Change: +0.25%","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0320765489.SGD":"FTIF - Franklin Mutual US Value A Acc SGD","BK1515":"抗疫概念","BK4585":"ETF&股票定投概念","LU0130102774.USD":"Natixis Harris Associates US Equity RA USD","LU0648000940.SGD":"Natixis Harris Associates Global Equity RA SGD","BK1574":"生物医药B类股","LU0070302665.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) ACC","BK4555":"新能源车","BK4566":"资本集团","LU0648001328.SGD":"Natixis Harris Associates US Equity RA SGD","06185":"康希诺生物","LU0130103400.USD":"Natixis Harris Associates Global Equity RA USD","LU0006061336.USD":"Blackrock US Small and MidCap Opportunities A2 USD","LU1201861165.SGD":"Natixis Harris Associates Global Equity PA SGD","BK4559":"巴菲特持仓","LU1201861249.SGD":"Natixis Harris Associates US Equity PA SGD-H","BK4526":"热门中概股","BK4588":"碎股","LU0211331839.USD":"FRANKLIN MUTUAL GLB DISCOVERY \"A\" (USD) ACC","LU0980610538.SGD":"Natixis Harris Associates US Equity RA SGD-H","BK4574":"无人驾驶","BK1191":"制药","BK4561":"索罗斯持仓","BK1161":"生物科技","HKD":"尚乘数科","BK4099":"汽车制造商","LU0208291251.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) INC","GM":"通用汽车","BK4023":"应用软件"},"translate_title":"康希诺生物高级管理层将增加持股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HKD":1,"06185":0.9,"GM":0.81},"content_text":"Certain members of the higher management of Cansino Biologics (HKG:6185) are planning to buy H shares of the company in the open market within the next six months, a June 21 bourse disclosure said.Chairman, CEO, and GM Xuefeng Yu; COO and deputy GM Shou Bai Chao; chief scientific officer and deputy GM Tao Zhu; and chief commercial officer and deputy GM Jing Wang will be purchasing additional shares.Yu and Zhu are also controlling shareholders of the Chinese biotechnology company while Chao and Wang are executive directors.The total value of the shares purchased by the interest parties is expected to be confined to HK$10 million.Price (HKD): $20.10, Change: $+0.05, Percent Change: +0.25%","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2445073141"}